After an adjustment for the presence of diabetes mellitus, arterial hypertension and smoking, all parameters excepting hyperLp(a) and the percentage of intermediate CD14++CD16+ monocytes lost their significance as a risk factor for triple-vessel CAD. The gene discussed is CD14; the disease is Hypertension.